Storage of ampoules containing pharmaceutical formulations using a sealed container comprising an oxygen scavenger

US9908682B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9908682-B2
Application numberUS-201414475819-A
CountryUS
Kind codeB2
Filing dateSep 3, 2014
Priority dateJan 9, 2007
Publication dateMar 6, 2018
Grant dateMar 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Ampoules made of plastics material and containing 0.5 to 5 ml of a pharmaceutical formulation are sealed, together with an oxygen scavenger, within a pouch.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of reducing oxidative degradation of the contents of ampoules comprising the steps of: (a) preparing a plurality of ampoules consisting essentially of a plastics material and manufactured using a blow-fill-seal method under normal atmospheric conditions, wherein the ampoules contain a solution of an inhalation pharmaceutical in a pharmaceutically acceptable carrier, (b) sealing a packet or sachet comprising an oxygen scavenger and the plurality of ampoules in a resealable container under normal atmospheric conditions, wherein the resealable container is made of a material comprising a metal or metal compound and is gas impermeable; (c) unsealing the container under normal atmospheric conditions and removing one or more ampoules; and (d) resealing the container under normal atmospheric conditions while the packet or sachet comprising the oxygen scavenger and at least one ampoule remain in the container, wherein, in the absence of an oxygen scavenger, the plurality of ampoules and the resealable container maintain separate environments, and wherein a first oxygen concentration in a headspace of at least one ampoule prior to sealing in the resealable container is greater than a second oxygen concentration in the headspace of the at least one ampoule after sealing the resealable container. 2. The method of claim 1 wherein the plurality of ampoules is 10 or more ampoules. 3. The method of claim 1 wherein the oxygen scavenger can absorb 20 to 2000 cc of oxygen. 4. The method of claim 1 wherein the metal or metal compound is aluminum. 5. The method of claim 1 wherein the container is a pouch. 6. The method of claim 1 wherein the plurality of ampoules contain up to 10 mL of the solution of the inhalation pharmaceutical in the pharmaceutically acceptable carrier. 7. The method of claim 1 wherein the inhalation pharmaceutical comprises levalbuterol and ipratropium bromide.

Assignees

Inventors

Classifications

  • Bag-type containers · CPC title

  • B65D81/266Primary

    for absorbing gases, e.g. oxygen absorbers or desiccants (B65D51/244, B65D51/30 take precedence) · CPC title

  • Bronchodilators · CPC title

  • Flexible ampoules, the contents of which are expelled by squeezing · CPC title

  • the absorber being enclosed in a small pack, e.g. bag, included in the package · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9908682B2 cover?
Ampoules made of plastics material and containing 0.5 to 5 ml of a pharmaceutical formulation are sealed, together with an oxygen scavenger, within a pouch.
Who is the assignee on this patent?
Allergan Pharmaceuticals Int Ltd
What technology area does this patent fall under?
Primary CPC classification B65D81/266. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).